abrdn Life Sciences Investors
HQL
45 hedge funds and large institutions have $59.6M invested in abrdn Life Sciences Investors in 2015 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 17 increasing their positions, 12 reducing their positions, and 5 closing their positions.
42% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 12
10% more capital invested
Capital invested by funds: $54.3M → $59.6M (+$5.23M)
0% more funds holding
Funds holding: 45 → 45 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
0.14% less ownership
Funds ownership: 14.29% → 14.14% (-0.14%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LPL Financial
San Diego,
California
|
+$964K |
| 2 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$789K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$752K |
| 4 |
DA
Doliver Advisors
Houston,
Texas
|
+$592K |
| 5 |
Morgan Stanley
New York
|
+$482K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$1.31M |
| 2 |
NIM
Needham Investment Management
New York
|
-$1.3M |
| 3 |
NPC
National Planning Corporation
El Segundo,
California
|
-$732K |
| 4 |
UR
USCA RIA
Houston,
Texas
|
-$438K |
| 5 |
Stifel Financial
St. Louis,
Missouri
|
-$291K |
HQL Hedge Fund Activity: Q1 2015 in Review
45 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in abrdn Life Sciences Investors (HQL) for Q1 2015, worth a combined $59.6M — up 9.6% from $54.3M a quarter earlier.
Fund positioning in HQL was balanced in Q1 2015: 5 funds opened new positions, 5 closed out, 17 added to existing stakes and 12 trimmed.
The largest buyer was LPL Financial, adding an estimated $964K. The largest seller was Credit Suisse, cutting an estimated $1.31M.
- 45 institutional investors held abrdn Life Sciences Investors (HQL) as of Q1 2015, unchanged from Q4 2014.
- Funds reported $59.6M of abrdn Life Sciences Investors stock for Q1 2015, up 9.6% quarter-over-quarter.
- 5 funds opened new abrdn Life Sciences Investors positions in Q1 2015 and 5 closed out, a net change of 0 holders.
- The largest abrdn Life Sciences Investors buyer in Q1 2015 was LPL Financial, an estimated $964K added.
- The largest abrdn Life Sciences Investors seller in Q1 2015 was Credit Suisse, an estimated $1.31M sold.
Based on aggregated 13F filings for Q1 2015.